LG AI Research Announces Collaboration with D&D Pharmatech to accelerate next-generation oral peptide drug discovery
- LG to secure leadership in the AI-bio market with its distinctive technological edge. SEOUL, South Korea, June 17, 2026 /PRNewswire/ -- LG AI Research announced today that it has signed a master agreement for a joint next-generation oral peptide drug development project with D&D...
- LG to secure leadership in the AI-bio market with its distinctive technological edge. SEOUL, South Korea, June 17, 2026 /PRNewswire/ -- LG AI Research announced today that it has signed a master agreement for a joint next-generation oral peptide drug development project with D&D...
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.